Philadelphia Doctor Awarded Outstanding Clinical Endocrinologist Award

Guenther Boden, MD received the AACE Outstanding Clinical Endocrinologist Award at the AACE 21st Annual Scientific & Clinical Congress in Philadelphia, on May 27, 2012.

Tuesday, May 22, 2012 4:53 pm EDT

Dateline:

Philadelphia, Pa.
EmailPDFPrintRSS
"I am very pleased to have been selected as the 2012 Outstanding Clinical Endocrinologist by AACE"

Guenther Boden, MD received the AACE Outstanding Clinical Endocrinologist Award at the AACE 21st Annual Scientific & Clinical Congress in Philadelphia, on May 27, 2012.

The AACE Outstanding Clinical Endocrinologist Award is given in recognition of dedicated and compassionate care provided to patients with endocrine diseases, exceptional knowledge and expertise in the field of clinical endocrinology and active advocacy of AACE’s mission in both professional and public environments.

“I am very pleased to have been selected as the 2012 Outstanding Clinical Endocrinologist by AACE,” Dr. Boden said. “I consider it a great honor to be recognized with this award for more than 40 years of service as a clinician and clinical investigator in the field of diabetes and other endocrine disorders.”

Dr. Boden has worked in the field of diabetes as a clinician and investigator for 40 over years.  He began as Director of the Diabetes Outpatient Clinic at Temple University Hospital in Philadelphia in 1975 and in 1978 was named Chief of the Section of Diabetes. After 11 years, Dr. Boden became Chief of the Division of Endocrinology/Diabetes/Metabolism and Program Director of the General Clinical Research Center at Temple University School of Medicine.

During this time, his laboratory, which has been supported uninterruptedly by the National institutes of Health since 1973, made several seminal observations.  Dr. Boden was the first to demonstrate that elevated plasma FFA levels produce peripheral insulin resistance (Journal of Clinical Investigation,1991, 1994 and 1995) and that lowering of chronically elevated plasma FFAs in obese, non-diabetic and diabetic patients improved insulin sensitivity (Diabetes1999).  These results have since been widely confirmed and suggested that FFAs can account for up to 50 percent of insulin resistance in obese patients with type 2 diabetes.

Dr. Boden’s biography and high resolution photo are available here.

About the American Association of Clinical Endocrinologists (AACE)
AACE is a professional medical organization with more than 6,500 members in the United States and 91 other countries. AACE members are physicians who specialize in endocrinology, diabetes and metabolism. For more information about AACE, visit our Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow us on Twitter at www.twitter.com/theaace.